Evidence map›Paper›PMID 23532100›Full record

ArticleThe Journal of infectious diseases2013

The role of staphylothrombin-mediated fibrin deposition in catheter-related Staphylococcus aureus infections.

Thomas Vanassche, Marijke Peetermans, Lucas N L Van Aelst, Willy E Peetermans, Jan Verhaegen, Dominique M Missiakas, Olaf Schneewind, Marc F Hoylaerts, Peter Verhamme

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Mechanisms of antimicrobial resistance in biofilms.npj antimicrobials and resistance · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Arteriosclerosis, thrombosis, and vascular biology · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Three-DimensionalInfection and immunity · 2020
    Article
  15. Article
  16. Article
  17. Different Types of Coagulase Are Associated With 28-Day Mortality in Patients WithFrontiers in cellular and infection microbiology · 2020
    Article
  18. Article
  19. Article
  20. An Inhibitory Effect of Dryocrassin ABBA onFrontiers in microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Thomas VanasscheCenter for Molecular and Vascular Biology, Department of Cardiovascular Sciences, University of Leuven, Herestraat 49, B-3000 Leuven, Belgium. thomas.vanassche@med.kuleuven.be
Marijke Peetermans
Lucas N L Van Aelst
Willy E Peetermans
Jan Verhaegen
Dominique M Missiakas
Olaf Schneewind
Marc F Hoylaerts
Peter Verhamme
Center for Vascular Biology Research · USUniversity of Chicago · USKU Leuven · BE

Funding

Molecular basis and intervention of Staphylococcus aureus agglutinationR01AI110937 · NIAID · UNIVERSITY OF CHICAGO · PI MISSIAKAS, DOMINIQUE M. · 2015 to 2019
$1.8M
NIAID NIH HHS R01 AI110937
6 · The paper itself

Abstract

Staphylococcus aureus (S. aureus) is a frequent cause of catheter-related infections. S. aureus secretes the coagulases staphylocoagulase and von Willebrand factor-binding protein, both of which form a staphylothrombin complex upon binding to prothrombin. Although fibrinogen and fibrin facilitate the adhesion of S. aureus to catheters, the contribution of staphylothrombin-mediated fibrin has not been examined. In this study, we use a S. aureus mutant lacking both coagulases (Δcoa/vwb) and dabigatran, a pharmacological inhibitor of both staphylothrombin and thrombin, to address this question. Genetic absence or chemical inhibition of pathogen-driven coagulation reduced both fibrin deposition and the retention of S. aureus on catheters in vitro. In a mouse model of jugular vein catheter infection, dabigatran reduced bacterial load on jugular vein catheters, as well as metastatic kidney infection. Importantly, inhibition of staphylothrombin improved the efficacy of vancomycin treatment both in vitro and in the mouse model.

Indexed as

AnimalsBacterial AdhesionBacterial LoadBenzimidazolesbeta-AlanineCatheter-Related InfectionsCentral Venous CathetersCoagulaseDabigatranDisease Models, AnimalFibrinJugular VeinsMaleMiceMice, Inbred BALB CStaphylococcal InfectionsBenzimidazolesbeta-AlanineCoagulaseDabigatranFibrinstaphylothrombinThrombincatheter infectiondabigatranstaphylocoagulaseStaphylococcus aureusstaphylothrombinvon Willebrand factor-binding protein

Identifiers

PMID23532100
PMCPMC6281407
OpenAlexW2149660414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.